皮质状血管内皮瘤 - - 它的病史,临床特征,分子生物学和当前治疗方法
Kenji Tsuchihashi1, Eishi Baba2
1Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Japanese journal of clinical oncology
|March 31, 2024
概括
皮质状血管内皮瘤 (EHE) 是一种罕见的血管瘤,通常是由融合基因驱动的. 了解其分子生物学是开发这种多样性疾病的新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 血管生物学 血管生物学
- 遗传学 是一个遗传学.
背景情况:
- 皮质状血管内皮瘤 (EHE) 是一种罕见的内皮细胞瘤.
- 世卫组织的分类将EHE指定为血管瘤.
- EHE的特点是特定的融合基因 (例如,WWTR1-CAMTA1,YAP1-TFE3).
研究的目的:
- 为提供一个全面的Epithelioid Hemangioendothelioma (EHE) 的综述.
- 涵盖历史背景,临床特征,分子生物学和当前的治疗方法.
- 突出了解EHE生物学和治疗策略的最新进展.
主要方法:
- 关于表皮质血管内皮瘤 (EHE) 的文献综述.
- 对临床表现和器官参与的分析.
- 检查分子生物学,包括通过下一代测序识别的融合基因和突变.
主要成果:
- 艾滋病在广泛的年龄范围内出现,通常在50岁左右,并且可以影响多个器官.
- 预后和行为因主要瘤部位而异.
- 主动监测和外科干预是主要的治疗方法; 进展性疾病的化疗.
结论:
- 了解EHE融合基因的进步对于新疗法开发至关重要.
- 持续研究EHE生物学,包括融合基因失调,预计将产生新的治疗策略.
- 本综述综合了关于EHE的当前知识,为未来的研究和临床实践提供了信息.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
159
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
159
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


